BioWorld

Sep. 8, 2005

Alnylam Shares Riding High On Mammoth Novartis Deal

Series A Brings OncoMed $14M For Cancer Stem Cell Products

Other News To Note

GSK Offering $1.4B To Buy ID Biomedical, Flu Vaccine

In what could be the largest vaccine transaction in history, GlaxoSmithKline plc offered to acquire ID Biomedical for $1.4 billion. (BioWorld Today) Read More

Today's news in brief

BioWorld

BioWorld briefs for Jan 20, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 20, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...